These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18476469)

  • 21. The effect of binders on the bioavailability of ofloxacin tablets in animal model.
    Rasool F; Ahmad M; Khan HM; Akhtar N; Murtaza G
    Acta Pol Pharm; 2010; 67(2):185-9. PubMed ID: 20369796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pefloxacin (Abaktal)--efficacy in treating severe infections, optimization of treatment based on pharmacokinetic and pharmacodynamic parameters].
    Budanov SV; Vasil'ev AN; Smirnov LB
    Antibiot Khimioter; 2002; 47(12):31-6. PubMed ID: 12728632
    [No Abstract]   [Full Text] [Related]  

  • 23. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H; Quentin C; de Barbeyrac B; Bebear C
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrier-mediated system for pefloxacin uptake in human monocytes.
    Mémin E; Panteix G; Revol A
    J Antimicrob Chemother; 1997 Aug; 40(2):263-8. PubMed ID: 9301993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ofloxacin for the treatment of leprosy.
    Ji B; Grosset J
    Acta Leprol; 1991; 7(4):321-6. PubMed ID: 1950440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
    Padeĭskaia EN; Mnatsakanian VE
    Antibiot Khimioter; 1991 Jul; 36(7):25-8. PubMed ID: 1953184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits.
    Wada T; Kozai S; Tajika T; Sakaki H; Suzuki T; Ohashi Y
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):278-89. PubMed ID: 18462067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
    Griffiths NM; Hirst BH; Simmons NL
    J Pharmacol Exp Ther; 1994 May; 269(2):496-502. PubMed ID: 8182517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of ofloxacin, pefloxacin, and tobramycin on the hydrophobicity of Klebsiella pneumoniae].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1999 Feb; 48(1):28-30. PubMed ID: 11038674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aqueous penetration of gatifloxacin and levofloxacin into the rabbit aqueous humor following topical dosing.
    Levine JM; Noecker RJ; Lane LC; Snyder RW; Rapedius M; Blanchard J
    J Ocul Pharmacol Ther; 2004 Jun; 20(3):210-6. PubMed ID: 15279726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens.
    Pant S; Rao GS; Sastry KV; Tripathi HC; Jagmohan ; Malik JK
    Br Poult Sci; 2005 Oct; 46(5):615-20. PubMed ID: 16359117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy.
    Fajardo TT; Villahermosa LG; Cruz EC; Cellona RV; Balagon MV; Abalos RM; Gelber RH
    Lepr Rev; 2004 Dec; 75(4):389-97. PubMed ID: 15685736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic effects of WP-0405, a thermo-setting ofloxacin gel, on methicillin-resistant Staphylococcus aureus keratitis in rabbits.
    Fukaya Y; Kurita A; Tsuruga H; Naito A; Nakaya S; Sato M; Kamata Y; Hirata H; Kambara Y; Kurasawa N; Wada T; Toyoda Y; Shirasawa E; Ohashi Y
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):258-66. PubMed ID: 16910867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-marketing surveillance of generic amoxicillin using a microbiological assay and pharmacokinetic approach in rats.
    de Mattos LIS; Ferraris FK; Machado TSC; de Brito TM; Chaves AS; Pereira HM; Pinto DP; da Silva DMD; Amendoeira FC
    Int J Antimicrob Agents; 2016 Dec; 48(6):753-756. PubMed ID: 27838279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender differences on bioavailabity of ofloxacin.
    Zulfiqar-ul-Hassan ; Riffat S; Naseer R
    J Ayub Med Coll Abbottabad; 2008; 20(2):114-7. PubMed ID: 19385473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of systemic absorption between ofloxacin ophthalmic in situ gels and ofloxacin conventional ophthalmic solutions administration to rabbit eyes by HPLC-MS/MS.
    Li J; Zhao H; Okeke CI; Li L; Liu Z; Yin Z; Zhuang P; Sun J; Wu T; Wang M; Li N; Pi J; Zhang Q; Zhang R; Ma L; Pang X; Liu Z; Zhang L; Fan L
    Int J Pharm; 2013 Jun; 450(1-2):104-13. PubMed ID: 23612359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactive alterations of arsenic and malathion in the disposition kinetics of pefloxacin.
    Babu NS; Malik JK; Rao GS; Aggarwal M; Ranganathan V
    Arch Environ Contam Toxicol; 2006 May; 50(4):587-93. PubMed ID: 16446993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Green magnetic nanomaterial as antibiotic release vehicle: The release of pefloxacin and ofloxacin.
    Cai W; Weng X; Zhang W; Chen Z
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111439. PubMed ID: 33255032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tenotoxic potential of fluoroquinolones in the choice of surgical antibiotic prophylaxis in ophthalmology].
    Pouzaud F; Rat P; Cambourieu C; Nourry H; Warnet JM
    J Fr Ophtalmol; 2002 Nov; 25(9):921-6. PubMed ID: 12515937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.